BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1 Study in China of GFH375 (VS-7375), an Oral KRAS G12D (ON/OFF) Inhibitor

  June 2, 2025

   · 

  7 min read
• Press Releases

  Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub

  June 2, 2025

   · 

  3 min read
• Press Releases

  UroGen Presents uTRACT Registry at ASCO 2025 Annual Meeting Designed to Study Real-World Use of JELMYTO in Low-Grade Upper Tract Urothelial Cancer

  June 2, 2025

   · 

  9 min read
• Press Releases

  OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Vaccine Tedopi® in Pancreatic Cancer and Non-Small Cell Lung Cancer

  June 2, 2025

   · 

  9 min read
• Press Releases

  OKI Establishes OKI Berlin Lab R&D Center in Berlin, Germany

  June 2, 2025

   · 

  3 min read
• Press Releases

  Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel in Metastatic Triple-Negative Breast Cancer Presented at ASCO 2025

  June 2, 2025

   · 

  6 min read
• Press Releases

  Genentech’s Tecentriq Combined with Lurbinectedin Shows Significant Survival Benefit in Extensive-Stage Small Cell Lung Cancer

  June 2, 2025

   · 

  9 min read
• Press Releases

  Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering

  June 2, 2025

   · 

  5 min read
• Press Releases

  Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to six newly-hired non-executive employees

  June 2, 2025

   · 

  1 min read
• Press Releases

  Minerva Biotechnologies - Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells

  June 2, 2025

   · 

  1 min read